281 related articles for article (PubMed ID: 17609444)
1. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression.
Takaki H; Yamakado K; Nakatsuka A; Fuke H; Murata K; Shiraki K; Takeda K
J Vasc Interv Radiol; 2007 Jul; 18(7):856-61. PubMed ID: 17609444
[TBL] [Abstract][Full Text] [Related]
2. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria.
Guo Y; Zhang Y; Huang J; Chen X; Huang W; Shan H; Zhu K
J Vasc Interv Radiol; 2016 Apr; 27(4):487-95. PubMed ID: 26922006
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy.
Takaki H; Yamakado K; Sakurai H; Nakatsuka A; Shiraki K; Isaji S; Takeda K
AJR Am J Roentgenol; 2011 Aug; 197(2):488-94. PubMed ID: 21785099
[TBL] [Abstract][Full Text] [Related]
6. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
Woo S; Lee JM; Yoon JH; Joo I; Kim SH; Lee JY; Yoon JH; Kim YJ; Han JK; Choi BI
Radiology; 2013 Aug; 268(2):589-600. PubMed ID: 23513241
[TBL] [Abstract][Full Text] [Related]
7. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe.
Fujimori M; Takaki H; Nakatsuka A; Uraki J; Yamanaka T; Hasegawa T; Shiraki K; Takei Y; Yamakado K
J Vasc Interv Radiol; 2012 Dec; 23(12):1622-8. PubMed ID: 23177108
[TBL] [Abstract][Full Text] [Related]
9. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?
Shibata T; Isoda H; Hirokawa Y; Arizono S; Shimada K; Togashi K
Radiology; 2009 Sep; 252(3):905-13. PubMed ID: 19567647
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation.
Lee MW; Kim YJ; Park SW; Hwang JH; Jung SI; Jeon HJ; Kwon WK
Br J Radiol; 2009 Nov; 82(983):908-15. PubMed ID: 19433482
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm.
Takaki H; Yamakado K; Uraki J; Nakatsuka A; Fuke H; Yamamoto N; Shiraki K; Yamada T; Takeda K
J Vasc Interv Radiol; 2009 Feb; 20(2):217-24. PubMed ID: 19097810
[TBL] [Abstract][Full Text] [Related]
12. Completeness of treatment in hepatocellular carcinomas treated with image-guided tumor therapies: Evaluation of positive predictive value of contrast-enhanced CT with histopathologic correlation in the explanted liver specimen.
Kim YS; Rhim H; Lim HK; Park CK; Lee WJ; Do YS; Cho JW
J Comput Assist Tomogr; 2006; 30(4):578-82. PubMed ID: 16845287
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.
Yin X; Zhang L; Wang YH; Zhang BH; Gan YH; Ge NL; Chen Y; Li LX; Ren ZG
BMC Cancer; 2014 Nov; 14():849. PubMed ID: 25409554
[TBL] [Abstract][Full Text] [Related]
14. Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma After Combined Transarterial Chemoembolization and Radiofrequency Ablation.
Song KD; Lee MW; Rhim H; Kim YS; Kang TW; Shin SW; Cho SK
AJR Am J Roentgenol; 2016 Nov; 207(5):1122-1127. PubMed ID: 27575338
[TBL] [Abstract][Full Text] [Related]
15. Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression.
Park Y; Kim YS; Rhim H; Lim HK; Choi D; Lee WJ
AJR Am J Roentgenol; 2009 Sep; 193(3):757-63. PubMed ID: 19696290
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
Gasparini D; Sponza M; Marzio A; Zanardi R; Bazzocchi M; Cemal Y
Radiol Med; 2002; 104(5-6):412-20. PubMed ID: 12589262
[TBL] [Abstract][Full Text] [Related]
17. Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas.
Yamanaka T; Yamakado K; Takaki H; Nakatsuka A; Shiraki K; Hasegawa H; Takei Y; Takeda K
Jpn J Radiol; 2012 Aug; 30(7):553-9. PubMed ID: 22610876
[TBL] [Abstract][Full Text] [Related]
18. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
Saviano A; Iezzi R; Giuliante F; Salvatore L; Mele C; Posa A; Ardito F; De Gaetano AM; Pompili M;
J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
[TBL] [Abstract][Full Text] [Related]
19. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS
Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201
[TBL] [Abstract][Full Text] [Related]
20. Survival with up to 10-year follow-up after combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma: single-center experience.
Fujimori M; Takaki H; Nakatsuka A; Uraki J; Yamanaka T; Hasegawa T; Shiraki K; Takei Y; Sakuma H; Yamakado K
J Vasc Interv Radiol; 2013 May; 24(5):655-66. PubMed ID: 23428356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
